These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21621603)

  • 61. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis.
    Fernández-Hidalgo N; Almirante B; Gavaldà J; Gurgui M; Peña C; de Alarcón A; Ruiz J; Vilacosta I; Montejo M; Vallejo N; López-Medrano F; Plata A; López J; Hidalgo-Tenorio C; Gálvez J; Sáez C; Lomas JM; Falcone M; de la Torre J; Martínez-Lacasa X; Pahissa A
    Clin Infect Dis; 2013 May; 56(9):1261-8. PubMed ID: 23392394
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial.
    Jørgensen KK; Olsen IC; Goll GL; Lorentzen M; Bolstad N; Haavardsholm EA; Lundin KEA; Mørk C; Jahnsen J; Kvien TK;
    Lancet; 2017 Jun; 389(10086):2304-2316. PubMed ID: 28502609
    [TBL] [Abstract][Full Text] [Related]  

  • 63. How safe is infliximab therapy during pregnancy and lactation in inflammatory bowel disease?
    Chaparro M; Gisbert JP
    Expert Opin Drug Saf; 2014 Dec; 13(12):1749-62. PubMed ID: 25244582
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ciclosporin use during pregnancy.
    Paziana K; Del Monaco M; Cardonick E; Moritz M; Keller M; Smith B; Coscia L; Armenti V
    Drug Saf; 2013 May; 36(5):279-94. PubMed ID: 23516008
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study.
    Weber-Schoendorfer C; Oppermann M; Wacker E; Bernard N; ; Beghin D; Cuppers-Maarschalkerweerd B; Richardson JL; Rothuizen LE; Pistelli A; Malm H; Eleftheriou G; Kennedy D; Kadioglu Duman M; Meister R; Schaefer C
    Br J Clin Pharmacol; 2015 Oct; 80(4):727-39. PubMed ID: 25808588
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management.
    Makol A; Wright K; Amin S
    Drugs; 2011 Oct; 71(15):1973-87. PubMed ID: 21985166
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Exposure to Infliximab During Pregnancy: Post-Marketing Experience.
    Geldhof A; Slater J; Clark M; Chandran U; Coppola D
    Drug Saf; 2020 Feb; 43(2):147-161. PubMed ID: 31677004
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Use of tumor necrosis factor-alpha inhibitors during pregnancy among women who delivered live born infants.
    Eworuke E; Panucci G; Goulding M; Neuner R; Toh S
    Pharmacoepidemiol Drug Saf; 2019 Mar; 28(3):296-304. PubMed ID: 30430682
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The pathogenesis of rheumatoid arthritis.
    McInnes IB; Schett G
    N Engl J Med; 2011 Dec; 365(23):2205-19. PubMed ID: 22150039
    [No Abstract]   [Full Text] [Related]  

  • 70. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data.
    Nikiphorou E; Kautiainen H; Hannonen P; Asikainen J; Kokko A; Rannio T; Sokka T
    Expert Opin Biol Ther; 2015; 15(12):1677-83. PubMed ID: 26549204
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The efficacy and safety of the biosimilar product (Inflectra
    Kaniewska M; Moniuszko A; Rydzewska G
    Prz Gastroenterol; 2017; 12(3):169-174. PubMed ID: 29123576
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Anti-TNF treatment during pregnancy and birth outcomes: A population-based study from Denmark, Finland, and Sweden.
    Bröms G; Kieler H; Ekbom A; Gissler M; Hellgren K; Lahesmaa-Korpinen AM; Pedersen L; Schmitt-Egenolf M; Sørensen HT; Granath F
    Pharmacoepidemiol Drug Saf; 2020 Mar; 29(3):316-327. PubMed ID: 32020767
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection.
    Julsgaard M; Christensen LA; Gibson PR; Gearry RB; Fallingborg J; Hvas CL; Bibby BM; Uldbjerg N; Connell WR; Rosella O; Grosen A; Brown SJ; Kjeldsen J; Wildt S; Svenningsen L; Sparrow MP; Walsh A; Connor SJ; Radford-Smith G; Lawrance IC; Andrews JM; Ellard K; Bell SJ
    Gastroenterology; 2016 Jul; 151(1):110-9. PubMed ID: 27063728
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines.
    Beaulieu DB; Ananthakrishnan AN; Martin C; Cohen RD; Kane SV; Mahadevan U
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):99-105. PubMed ID: 28870657
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development.
    Matro R; Martin CF; Wolf D; Shah SA; Mahadevan U
    Gastroenterology; 2018 Sep; 155(3):696-704. PubMed ID: 29857090
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Advances in pathogenesis and treatment of ocular involvement in Behcet's disease.
    Lin S; Xu Z; Lin Z; Xie B; Feng J
    Front Immunol; 2023; 14():1206959. PubMed ID: 37841268
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gestational Diabetes Mellitus and Maternal Immune Dysregulation: What We Know So Far.
    McElwain CJ; McCarthy FP; McCarthy CM
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923959
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An Anti-hTNF-α Variable New Antigen Receptor Format Demonstrates Superior
    Ubah OC; Steven J; Porter AJ; Barelle CJ
    Front Immunol; 2019; 10():526. PubMed ID: 30967865
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pyoderma gangrenosum in pregnancy successfully treated with infliximab and prednisone.
    Stiegler JD; Lucas CT; Sami N
    JAAD Case Rep; 2017 Sep; 3(5):387-389. PubMed ID: 28879220
    [No Abstract]   [Full Text] [Related]  

  • 80. Common Adverse Effects of Anti-TNF Agents on Gestation.
    Fasoulakis Z; Antsaklis P; Galanopoulos N; Kontomanolis E
    Obstet Gynecol Int; 2016; 2016():8648651. PubMed ID: 28044081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.